- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Age bows out as factor forrecurrence in DCIS patients
Younger women with ductal carcinoma insitu have traditionally been held to have ahigher risk of recurrence than older womenwith the condition. A new study from FoxChase Cancer Center inPhiladelphia, however,challenges this view.
Younger women with ductal carcinoma in situ have traditionally been held to have a higher risk of recurrence than older women with the condition. A new study from Fox Chase Cancer Center in Philadelphia, however, challenges this view.
Dr. Aruna Turaka and colleagues examined 440 patients with DCIS. All patients received whole-breast radiotherapy, and 95% received additional radiation to the excision site. Study results showed no statistically significant difference between younger and older patients when it came to recurrences.
Findings were released at the 2008 American Society for Therapeutic Radiology and Oncology meeting. "There is a trend toward increased risk in younger women, but it was not significant enough to show that they do badly compared with the older women," Turaka told Diagnostic Imaging.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
